Literature DB >> 32395833

Comparison of robust to standardized CT radiomics models to predict overall survival for non-small cell lung cancer patients.

Diem Vuong1, Marta Bogowicz1, Sarah Denzler1, Carol Oliveira1,2, Robert Foerster1, Florian Amstutz1, Hubert S Gabryś1, Jan Unkelbach1, Sven Hillinger3, Sandra Thierstein4, Alexandros Xyrafas4, Solange Peters5, Miklos Pless6, Matthias Guckenberger1, Stephanie Tanadini-Lang1.   

Abstract

BACKGROUND: Radiomics is a promising tool for the identification of new prognostic biomarkers. Radiomic features can be affected by different scanning protocols, often present in retrospective and prospective clinical data. We compared a computed tomography (CT) radiomics model based on a large but highly heterogeneous multicentric image dataset with robust feature pre-selection to a model based on a smaller but standardized image dataset without pre-selection.
MATERIALS AND METHODS: Primary tumor radiomics was extracted from pre-treatment CTs of IIIA/N2/IIIB NSCLC patients from a prospective Swiss multicentric randomized trial (npatient  = 124, ninstitution  = 14, SAKK 16/00) and a validation dataset (npatient  = 31, ninstitution  = 1). Four robustness studies investigating inter-observer delineation variation, motion, convolution kernel, and contrast were conducted to identify robust features using an intraclass correlation coefficient threshold >0.9. Two 12-months overall survival (OS) logistic regression models were trained: (a) on the entire multicentric heterogeneous dataset but with robust feature pre-selection (MCR) and (b) on a smaller standardized subset using all features (STD). Both models were validated on the validation dataset acquired with similar reconstruction parameters as the STD dataset. The model performances were compared using the DeLong test.
RESULTS: In total, 113 stable features were identified (nshape  = 8, nintensity  = 0, ntexture  = 7, nwavelet  = 98). The convolution kernel had the strongest influence on the feature robustness (<20% stable features). The final models of MCR and STD consisted of one and two features respectively. Both features of the STD model were identified as non-robust. MCR did not show performance significantly different from STD on the validation cohort (AUC [95%CI] = 0.72 [0.48-0.95] and 0.79 [0.63-0.95], p = 0.59).
CONCLUSION: Prognostic OS CT radiomics model for NSCLC based on a heterogeneous multicentric imaging dataset with robust feature pre-selection performed equally well as a model on a standardized dataset.
© 2020 American Association of Physicists in Medicine.

Entities:  

Keywords:  CT; lung cancer; multicentric; radiomics; robust; standardized

Mesh:

Year:  2020        PMID: 32395833     DOI: 10.1002/mp.14224

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  6 in total

1.  Standardised lesion segmentation for imaging biomarker quantitation: a consensus recommendation from ESR and EORTC.

Authors:  Nandita M deSouza; Aad van der Lugt; Christophe M Deroose; Angel Alberich-Bayarri; Luc Bidaut; Laure Fournier; Lena Costaridou; Daniela E Oprea-Lager; Elmar Kotter; Marion Smits; Marius E Mayerhoefer; Ronald Boellaard; Anna Caroli; Lioe-Fee de Geus-Oei; Wolfgang G Kunz; Edwin H Oei; Frederic Lecouvet; Manuela Franca; Christian Loewe; Egesta Lopci; Caroline Caramella; Anders Persson; Xavier Golay; Marc Dewey; James P B O'Connor; Pim deGraaf; Sergios Gatidis; Gudrun Zahlmann
Journal:  Insights Imaging       Date:  2022-10-04

2.  Impact of CT convolution kernel on robustness of radiomic features for different lung diseases and tissue types.

Authors:  Sarah Denzler; Diem Vuong; Marta Bogowicz; Matea Pavic; Thomas Frauenfelder; Sandra Thierstein; Eric Innocents Eboulet; Britta Maurer; Janine Schniering; Hubert Szymon Gabryś; Isabelle Schmitt-Opitz; Miklos Pless; Robert Foerster; Matthias Guckenberger; Stephanie Tanadini-Lang
Journal:  Br J Radiol       Date:  2021-02-05       Impact factor: 3.039

3.  A CT-Based Radiomics Approach to Predict Nivolumab Response in Advanced Non-Small-Cell Lung Cancer.

Authors:  Chang Liu; Jing Gong; Hui Yu; Quan Liu; Shengping Wang; Jialei Wang
Journal:  Front Oncol       Date:  2021-02-24       Impact factor: 6.244

4.  Radiomics Feature Activation Maps as a New Tool for Signature Interpretability.

Authors:  Diem Vuong; Stephanie Tanadini-Lang; Ze Wu; Robert Marks; Jan Unkelbach; Sven Hillinger; Eric Innocents Eboulet; Sandra Thierstein; Solange Peters; Miklos Pless; Matthias Guckenberger; Marta Bogowicz
Journal:  Front Oncol       Date:  2020-12-08       Impact factor: 6.244

5.  Quantification of the spatial distribution of primary tumors in the lung to develop new prognostic biomarkers for locally advanced NSCLC.

Authors:  Diem Vuong; Marta Bogowicz; Leonard Wee; Oliver Riesterer; Eugenia Vlaskou Badra; Louisa Abigail D'Cruz; Panagiotis Balermpas; Janita E van Timmeren; Simon Burgermeister; André Dekker; Dirk De Ruysscher; Jan Unkelbach; Sandra Thierstein; Eric I Eboulet; Solange Peters; Miklos Pless; Matthias Guckenberger; Stephanie Tanadini-Lang
Journal:  Sci Rep       Date:  2021-10-22       Impact factor: 4.379

6.  The impact of inter-observer variation in delineation on robustness of radiomics features in non-small cell lung cancer.

Authors:  Gargi Kothari; Beverley Woon; Cameron J Patrick; James Korte; Leonard Wee; Gerard G Hanna; Tomas Kron; Nicholas Hardcastle; Shankar Siva
Journal:  Sci Rep       Date:  2022-07-27       Impact factor: 4.996

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.